Frontiers | Highlights of the Latest Developments in Radiopharmaceuticals for Infection Imaging and Future Perspectives
COVID-19 pandemic has heightened the interest towards diagnosis and treatment of infectious diseases. Nuclear medicine with its powerful scintigraphic, SPECT and PET imaging modalities has always played an important role in diagnosis of infections and distinguishing them from the sterile inflammation. In addition to the clinically available radiopharmaceuticals there has been a decades-long effort to develop more specific imaging agents with some examples being radiolabeled antibiotics and antimicrobial peptides for bacterial imaging, radiolabeled anti-fungals for fungal infections imaging, ra...
Source: frontiersin.org